首页> 外国专利> MicroRNA expression signature to predict survival and metastasis in hepatocellular carcinoma

MicroRNA expression signature to predict survival and metastasis in hepatocellular carcinoma

机译:MicroRNA表达特征可预测肝细胞癌的生存和转移

摘要

A method for predicting survival of a subject with hepatocellular carcinoma (HCC), quecomprende measuring the level of a gene product of a miR in a test sample of subject tumoralesdel cells, wherein an alteration in the level of gene product miR in the test sample, relative withthe corresponding level of a miR gene product in a control free HCC tissue metastases esindicativa survival of the subject sample in which the miR gene product comprises: miR-30c [SEC . ID NO: 6], miR-124a [SEQ. ID NO: 4], miR-207 [SEQ. ID NO: 18] and miR-219 [SEQ. ID NO: 20], and wherein said alteracióncomprende increased expression levels of miR-219 [SEQ. ID NO: 20] and miR-207 [SEQ. ID NO: 18] and ladisminución levels of miR-30c [SEQ. ID NO: 6] and miR-124a [SEQ. ID NO: 4], which correlates with bajasupervivencia.
机译:一种用于预测患有肝细胞癌(HCC)的受试者的生存的方法,用于测量受试者的肿瘤细胞样品中miR的基因产物的水平,其中所述受试者中的基因产物miR的水平发生变化,相对于miR基因产物在对照的游离HCC组织转移中的相应水平而言,该受试者样品的esindicativa存活是其中,miR基因产物包括:miR-30c [SEC。 ID NO:6],miR-124a [SEQ.ID.NO:6。 ID号:4],miR-207 [SEQ.ID.NO:4。 ID号:18]和miR-219 [SEQ.ID.NO:18。 ID ID:20],其中所述互变异构体增加了miR-219 [SEQ.ID.No.20]的表达水平。 ID NO:20]和miR-207 [SEQ。 IDR:18]和miR-30c的ladisminución水平[SEQ。 ID NO:6]和miR-124a [SEQ.ID.NO:6。 ID NO:4],与bajasupervivencia相关。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号